Učitavanje...
Inhaled Tobramycin Effectively Reduces FEV(1) Decline in Cystic Fibrosis. An Instrumental Variables Analysis
Rationale: The efficacy of inhaled tobramycin on chronic Pseudomonas aeruginosa infections in patients with cystic fibrosis (CF) has been established in clinical trials. However, little is known about its clinical effectiveness on lung function outside randomized controlled trial settings; conventio...
Spremljeno u:
| Izdano u: | Ann Am Thorac Soc |
|---|---|
| Glavni autori: | , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
American Thoracic Society
2013
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5475429/ https://ncbi.nlm.nih.gov/pubmed/23802816 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1513/AnnalsATS.201209-082OC |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|